
Metabolic
Retatrutide 30mg
Triple agonist: higher-fill research vial
Overview
Triple agonist: higher-fill research vial
The larger-fill configuration of retatrutide (LY-3437943), supplied for extended in-vitro concentration-response work. Identical molecule and sequence to the 20 mg vial, differing only in the quantity of lyophilized material per vial.
- Fill: 30 mg / vial
- Pack: 1 vial · 30 mg total
- Purity: ≥99%
For in-vitro laboratory research use only. Not for human or animal consumption, medical, diagnostic or therapeutic use.
Receptor pharmacology
Simultaneous GLP-1, GIP and glucagon receptor activation. Central appetite regulation, peripheral insulin sensitization, and thermogenic energy expenditure combine to drive fat mass loss with preserved glycemic control.
Laboratory handling
Research use disclaimer
Sacred Peptides does not provide dosing recommendations for human use. Retatrutide 30mg is supplied for in-vitro laboratory research only. Any concentration ranges referenced on this page or in cited studies describe the parameters used in that research and are not instructions.
- Not a drug. Not approved by Health Canada or the FDA for human use.
- Not intended to diagnose, treat, cure, or prevent any disease.
- Not for use in humans, pregnant or nursing individuals, or animals outside a controlled research setting.
- Handling, storage, and disposal are the responsibility of a qualified researcher.